Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Plant preparation composition for treating lung cancer and preparation and use methods thereof

A technology for botanical preparations and compositions, which can be used in drug combinations, medical raw materials derived from ferns/filamentous plants, and plant raw materials, etc., and can solve problems such as poor treatment effect, neglect, and accumulated toxicity.

Inactive Publication Date: 2020-09-04
陈爱红
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The technical problems to be solved are: lung cancer is easy to transfer, the common treatment methods, such as surgery and radiotherapy, have poor therapeutic effects, chemotherapy drugs are expensive and have cumulative toxicity, and the common treatment methods ignore the improvement of the patient's physical symptoms and the patient's tolerance. relief of symptoms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Plant preparation composition for treating lung cancer and preparation and use methods thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0086] Embodiment 1: Weigh the following raw materials in parts by weight: 36000 parts of water; 8 parts of tripterygium alkaloids; 8 parts of triptolide; 90 parts of winter glucose; 85 parts of Ganoderma lucidum polysaccharide; 90 parts of fritillary alkaloid; 90 parts of Luo Han Guo protein; ; 90 parts of cypress alkaloids; 85 parts of salvianic acid; 90 parts of coix lactone; 90 parts of poria cocos polysaccharide; 85 parts of flavones; 90 parts of safflower glycosides; 60 parts of xanthanin; 85 parts of fumaric acid; 85 parts of glycyrrhizic acid; 85 parts of white cardamom volatile oil; ; 82 parts of pinellia sitosterol; 86 parts of Artemisia argyi essential oil; 85 parts of ginsenosides; 90 parts of pokeweed saponin; 90 parts; 86 parts of cistanche minerals; 90 parts of Chinese yam germanium; 90 parts of mulberry inorganic salt; 86 parts of grape polymerized phenol; 90 parts of various amino acids; 85 parts of emodin; 0.8 parts of folic acid; 6 parts of copper sulfate...

Embodiment 2

[0088] Embodiment 2: Weigh the following raw materials in parts by weight: 36000 parts of water; 7 parts of tripterygium alkaloids; 7 parts of triptolide; 90 parts of winter glucose; 85 parts of Ganoderma lucidum polysaccharide; 90 parts of fritillary alkaloid; 90 parts of Luo Han Guo protein; ; 90 parts of cypress alkaloids; 85 parts of salvianic acid; 90 parts of coix lactone; 90 parts of poria cocos polysaccharide; 85 parts of flavones; 90 parts of safflower glycosides; 60 parts of xanthanin; 85 parts of fumaric acid; 85 parts of glycyrrhizic acid; 85 parts of white cardamom volatile oil; ; 82 parts of pinellia sitosterol; 86 parts of Artemisia argyi essential oil; 85 parts of ginsenosides; 90 parts of pokeweed saponin; 90 parts; 86 parts of cistanche minerals; 90 parts of Chinese yam germanium; 90 parts of mulberry inorganic salt; 86 parts of grape polymerized phenol; 90 parts of various amino acids; 85 parts of emodin; 0.8 parts of folic acid; 6 parts of copper sulfate...

Embodiment 3

[0090] Embodiment 3: Weigh the following raw materials in parts by weight: 36000 parts of water; 6 parts of tripterygium alkaloids; 6 parts of triptolide; 90 parts of winter glucose; 85 parts of Ganoderma lucidum polysaccharide; 90 parts of fritillary alkaloid; 90 parts of Luo Han Guo protein; ; 90 parts of cypress alkaloids; 85 parts of salvianic acid; 90 parts of coix lactone; 90 parts of poria cocos polysaccharide; 85 parts of flavones; 90 parts of safflower glycosides; 60 parts of xanthanin; 85 parts of fumaric acid; 85 parts of glycyrrhizic acid; 85 parts of white cardamom volatile oil; 75 parts of lotus seed core alkaloids; ; 82 parts of pinellia sitosterol; 86 parts of Artemisia argyi essential oil; 85 parts of ginsenosides; 90 parts of pokeweed saponin; 90 parts; 86 parts of cistanche minerals; 90 parts of Chinese yam germanium; 90 parts of mulberry inorganic salt; 86 parts of grape polymerized phenol; 90 parts of various amino acids; 85 parts of emodin; 0.8 parts o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an antitumor drug and preparation and use methods thereof, and discloses a botanical preparation composition for treating the lung cancer and preparation and use methods thereof. The composition comprises multiple raw material medicines such as tripterygium wilfordii alkaloid, triptolide, gelsmium elegans humantenidine, chamaejasmin, alkannin, ophiopogon japonicus glucose,ganoderan, fritimine, siraitia grosvenorii protein, honeysuckle chlorogenic acid, prunella vulgaris terpenoid saponin, houttuyfonate, sculellaria barbata alkaloid, selaginella doederleinii hieron alkaloid, salvianolic acid, coix lachryma-jobi lactone, poria cocos hypoglycan, auriculasin, prepared rehmannia root amino acid, coastal glehnia root triterpenoid acid, areapillin, saussurine, pharbitin,sealwort quinones, heliscopiol, cassia seed physcion, lygodium japonicum chlorogenic acid, cynanchum paniculatum propiophenone, carthamin, xanthoxylin, fumaric acid, glycyrrhizic acid, amomum cardamomum volatile oil, lotus plumule alkaloid, hawthorn flavone, lily colchicine, omphalin, pinellia ternate sitosterol, artemisia vulgaris oil and ginsenoside.

Description

technical field [0001] The invention relates to an antineoplastic drug and its preparation method and use method, in particular to a herbal preparation composition for treating lung cancer and its preparation method and use method. Background technique [0002] Cancer cells are produced after the DNA of normal cells in the body is damaged, do not contain foreign proteins, cannot trigger the response of most immune cells in the body, and are not affected by humoral immunity at all, so it is difficult to heal itself. [0003] NK cells have no MHC restriction, and can non-specifically kill tumor cells and virus-infected lymphocytes without prior sensitization. They are the few immune cells in the body that can recognize and kill cancer cells. [0004] Lung cancer is one of the malignant tumors with the fastest increasing morbidity and mortality and the greatest threat to the health and life of the population. Lung cancer cells are not easy to be killed by NK cells (the relatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9064A61P35/00A61K31/122A61K31/165A61K31/43A61K31/519A61K31/56A61K31/575A61K31/585A61K31/704A61K33/30A61K33/32A61K33/34
CPCA61K9/0095A61K31/122A61K31/165A61K31/43A61K31/519A61K31/56A61K31/575A61K31/585A61K31/704A61K33/30A61K33/32A61K33/34A61K36/07A61K36/074A61K36/076A61K36/11A61K36/12A61K36/185A61K36/23A61K36/258A61K36/27A61K36/282A61K36/285A61K36/286A61K36/30A61K36/355A61K36/37A61K36/39A61K36/42A61K36/47A61K36/482A61K36/486A61K36/488A61K36/536A61K36/539A61K36/56A61K36/605A61K36/62A61K36/638A61K36/64A61K36/66A61K36/704A61K36/708A61K36/725A61K36/734A61K36/738A61K36/758A61K36/78A61K36/804A61K36/81A61K36/815A61K36/83A61K36/87A61K36/8888A61K36/8945A61K36/8966A61K36/8967A61K36/8968A61K36/8969A61K36/8994A61K36/9064A61K2236/331A61P35/00A61K2300/00
Inventor 陈爱红
Owner 陈爱红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com